Cargando…

Long-Term Outcomes after Surgery for Pheochromocytoma and Sympathetic Paraganglioma

SIMPLE SUMMARY: Pheochromocytoma and sympathetic paraganglioma (PHEO/sPGL) are rare and mainly sporadic tumors arising from chromaffin cells, for which hereditary variants occur in about one-third of cases. The discrimination between benign and malignant lesions is extremely challenging in PHEO/sPGL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torresan, Francesca, Beber, Arianna, Schiavone, Donatella, Zovato, Stefania, Galuppini, Francesca, Crimì, Filippo, Ceccato, Filippo, Iacobone, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252063/ https://www.ncbi.nlm.nih.gov/pubmed/37296853 http://dx.doi.org/10.3390/cancers15112890

Ejemplares similares

CT Texture Analysis of Adrenal Pheochromocytomas: A Pilot Study
por: Crimì, Filippo, et al.
Publicado: (2023)

Total adrenalectomy versus subtotal adrenalectomy for bilateral pheochromocytoma: meta-analysis
por: Schiavone, Donatella, et al.
Publicado: (2023)

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
por: Tizianel, Irene, et al.
Publicado: (2022)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
por: Ceccato, Filippo, et al.
Publicado: (2023)

Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients
por: Torresan, Francesca, et al.
Publicado: (2022)

Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas
por: Fagundes, Gustavo F C, et al.
Publicado: (2022)

Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients
por: Kim, Jung Hee, et al.
Publicado: (2021)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
por: Kim, Jung Hee, et al.
Publicado: (2022)

Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature
por: Torresan, Francesca, et al.
Publicado: (2019)

The role of procalcitonin in the follow-up of medullary thyroid cancer
por: Censi, Simona, et al.
Publicado: (2022)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications
por: Manso, Jacopo, et al.
Publicado: (2022)

Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
por: Constantinescu, Georgiana, et al.
Publicado: (2020)

A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy
por: Canu, Letizia, et al.
Publicado: (2021)

Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas
por: Bayley, Jean-Pierre, et al.
Publicado: (2022)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Dopamine-Secreting Pheochromocytoma and Paraganglioma
por: Miyamoto, Shotaro, et al.
Publicado: (2021)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017)

Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
por: De Filpo, Giuseppina, et al.
Publicado: (2023)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
por: Ku, Eu Jeong, et al.
Publicado: (2021)

Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas
por: Meijs, Anouk C, et al.
Publicado: (2021)

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials
por: Severi, S., et al.
Publicado: (2021)

Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma– SIZEPASS
por: Hanschell, Helena, et al.
Publicado: (2023)

Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
por: van den Berg, Marit F., et al.
Publicado: (2023)

Correction: Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
por: De Filpo, Giuseppina, et al.
Publicado: (2023)

A spontaneous paraganglioma–pheochromocytoma syndrome
por: Toutounchi, Sadegh, et al.
Publicado: (2013)

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches
por: Costa, Marcia Helena Soares, et al.
Publicado: (2015)

Paraganglioma or pheochromocytoma? A peculiar diagnosis
por: Marques, Ricardo Rodrigues, et al.
Publicado: (2018)

New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pgqqtegd62ji6sui659pnrs6ig